THEMISMED.BOTHEMISMED.BOBSE

Revenue (LTM)

$4.1B

+6.2% YoY

Net Income (LTM)

$298M

-31.5% YoY

Free Cash Flow

$193M

Revenue CAGR (5Y)

+15.0%

Marginsimproving

FCF$0.2B

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	2,307	3,946↑71.1%	3,543↓10.2%	3,818↑7.7%	4,055↑6.2%
Gross Profit	1,501	2,426↑61.6%	2,360↓2.7%	2,420↑2.6%	2,735↑13.0%
Operating Income	409	862↑110.4%	570↓33.9%	1,303↑128.8%	392↓70.0%
Net Income	357	729↑104.1%	569↓21.9%	435↓23.5%	298↓31.5%
EBITDA	531	1,022↑92.4%	790↓22.7%	733↓7.1%	490↓33.1%
EPS Diluted	3.88	7.91↑103.9%	6.17↓22.0%	4.72↓23.5%	3.24↓31.4%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	190	203↑6.6%	125↓38.1%	99↓20.9%	66↓33.9%
Total Current Assets	1,855	2,142↑15.5%	2,645↑23.5%	2,932↑10.8%	3,039↑3.6%
Total Assets	3,711	4,278↑15.3%	5,140↑20.1%	5,664↑10.2%	5,880↑3.8%
Total Current Liabilities	1,283	1,095↓14.6%	1,391↑27.0%	1,546↑11.1%	1,561↑1.0%
Total Liabilities	1,526	1,403↓8.1%	1,745↑24.4%	1,888↑8.2%	1,854↓1.8%
Total Equity	2,185	2,875↑31.6%	3,394↑18.1%	3,777↑11.3%	4,026↑6.6%
Total Debt	872	797↓8.5%	924↑15.9%	958↑3.7%	830↓13.4%
Net Debt	682	595↓12.8%	798↑34.3%	859↑7.6%	702↓18.3%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	570	344↓39.6%	161↓53.2%	221↑37.3%	347↑57.1%
Capital Expenditure	-180	-206↓14.3%	-287↓39.4%	-184↑35.9%	-154↑16.2%
Free Cash Flow	389	138↓64.6%	-127↓191.9%	37↑129.0%	193↑424.6%
Stock-Based Comp	0	0	0	0	0
Net Change in Cash	157	13↓92.0%	-77↓713.1%	-26↑66.1%	-34↓28.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance